(NASDAQ: PEPG) Pepgen's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 43.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.65%.
Pepgen's earnings in 2025 is -$93,557,000.On average, 8 Wall Street analysts forecast PEPG's earnings for 2025 to be -$163,620,773, with the lowest PEPG earnings forecast at -$177,865,405, and the highest PEPG earnings forecast at -$152,311,690. On average, 8 Wall Street analysts forecast PEPG's earnings for 2026 to be -$92,562,609, with the lowest PEPG earnings forecast at -$140,810,112, and the highest PEPG earnings forecast at -$62,801,503.
In 2027, PEPG is forecast to generate -$76,668,019 in earnings, with the lowest earnings forecast at -$94,322,563 and the highest earnings forecast at -$48,364,376.